28 November 2017

UCL and Synpromics to develop Parkinson's gene therapy

UCL is collaborating with Synpromics on a gene therapy for young-onset Parkinson's disease. The pact will see UCL work with Synpromics on synthetic gene promoters that enable highly specific gene therapies. Synpromics is bringing its expertise in synthetic gene promoters to the collaboration. These are DNA sequences that activate transcription, driving the synthesis of a protein associated with their target genes. Source: Fierce Biotech 28/11/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).